Editorial
EMA and national drug agencies: cooperation or competition?
Contribución de la Agencia Española de Medicamentos y Productos Sanitarios al Comité Europeo de Evaluación de Medicamentos de Uso Humano
R. Banzi
, S. Garattini
IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
Leído
999
Vecesse ha leído el artículo
822
Total PDF
177
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 0 | 1 | 1 |
| 2025 5 | 0 | 2 | 2 |
| 2025 4 | 0 | 2 | 2 |
| 2025 3 | 0 | 2 | 2 |
| 2025 2 | 0 | 2 | 2 |
| 2025 1 | 0 | 3 | 3 |
| 2024 12 | 0 | 3 | 3 |
| 2024 11 | 0 | 3 | 3 |
| 2024 10 | 0 | 9 | 9 |
| 2024 9 | 0 | 14 | 14 |
| 2024 8 | 0 | 11 | 11 |
| 2024 7 | 0 | 1 | 1 |
| 2024 6 | 0 | 4 | 4 |
| 2024 5 | 0 | 9 | 9 |
| 2024 4 | 0 | 8 | 8 |
| 2024 3 | 0 | 7 | 7 |
| 2024 2 | 0 | 7 | 7 |
| 2024 1 | 0 | 17 | 17 |
| 2023 12 | 0 | 13 | 13 |
| 2023 11 | 0 | 18 | 18 |
| 2023 10 | 0 | 19 | 19 |
| 2023 9 | 0 | 6 | 6 |
| 2023 8 | 0 | 10 | 10 |
| 2023 7 | 0 | 14 | 14 |
| 2023 6 | 0 | 19 | 19 |
| 2023 5 | 0 | 45 | 45 |
| 2023 4 | 0 | 24 | 24 |
| 2023 3 | 3 | 17 | 20 |
| 2023 2 | 0 | 17 | 17 |
| 2022 1 | 0 | 12 | 12 |
| 2022 12 | 0 | 17 | 17 |
| 2022 11 | 0 | 13 | 13 |
| 2022 10 | 0 | 7 | 7 |
| 2022 9 | 0 | 12 | 12 |
| 2022 8 | 0 | 23 | 23 |
| 2022 7 | 0 | 6 | 6 |
| 2022 6 | 0 | 4 | 4 |
| 2022 5 | 0 | 9 | 9 |
| 2022 4 | 0 | 7 | 7 |
| 2022 3 | 0 | 6 | 6 |
| 2022 2 | 0 | 3 | 3 |
| 2021 1 | 0 | 13 | 13 |
| 2021 12 | 0 | 11 | 11 |
| 2021 11 | 0 | 20 | 20 |
| 2021 10 | 0 | 12 | 12 |
| 2021 9 | 0 | 13 | 13 |
| 2021 8 | 0 | 15 | 15 |
| 2021 7 | 0 | 11 | 11 |
| 2021 6 | 0 | 3 | 3 |
| 2021 5 | 0 | 19 | 19 |
| 2021 4 | 0 | 25 | 25 |
| 2021 3 | 0 | 10 | 10 |
| 2021 2 | 0 | 8 | 8 |
| 2020 1 | 0 | 8 | 8 |
| 2020 12 | 0 | 3 | 3 |
| 2020 11 | 0 | 2 | 2 |
| 2020 10 | 0 | 1 | 1 |
| 2020 9 | 0 | 3 | 3 |
| 2020 8 | 0 | 5 | 5 |
| 2020 4 | 0 | 2 | 2 |
| 2020 3 | 0 | 3 | 3 |
| 2020 1 | 0 | 9 | 9 |
| 2019 12 | 0 | 7 | 7 |
| 2019 11 | 0 | 2 | 2 |
| 2019 9 | 1 | 1 | 2 |
| 2019 8 | 0 | 3 | 3 |
| 2019 7 | 0 | 7 | 7 |
| 2019 6 | 0 | 12 | 12 |
| 2019 5 | 0 | 19 | 19 |
| 2019 4 | 0 | 5 | 5 |
| 2019 3 | 0 | 4 | 4 |
| 2019 2 | 0 | 3 | 3 |
| 2019 1 | 0 | 2 | 2 |
| 2018 12 | 0 | 5 | 5 |
| 2018 11 | 0 | 4 | 4 |
| 2018 10 | 0 | 9 | 9 |
| 2018 9 | 0 | 1 | 1 |
| 2018 8 | 0 | 1 | 1 |
| 2018 7 | 0 | 1 | 1 |
| 2018 6 | 0 | 1 | 1 |
| 2018 5 | 0 | 9 | 9 |
| 2018 4 | 0 | 1 | 1 |
| 2018 2 | 22 | 5 | 27 |
| 2018 1 | 17 | 5 | 22 |
| 2017 12 | 20 | 1 | 21 |
| 2017 11 | 21 | 11 | 32 |
| 2017 10 | 16 | 8 | 24 |
| 2017 9 | 13 | 9 | 22 |
| 2017 8 | 14 | 9 | 23 |
| 2017 7 | 15 | 5 | 20 |
| 2017 6 | 20 | 13 | 33 |
| 2017 5 | 15 | 6 | 21 |
| 2017 4 | 0 | 1 | 1 |
| 2017 3 | 0 | 3 | 3 |
| 2017 2 | 0 | 2 | 2 |
| 2016 11 | 0 | 1 | 1 |
| 2016 10 | 0 | 4 | 4 |
| 2016 8 | 0 | 1 | 1 |
| 2016 6 | 0 | 2 | 2 |
| 2016 5 | 0 | 4 | 4 |
| 2016 4 | 0 | 5 | 5 |
| 2016 3 | 0 | 2 | 2 |
| 2016 2 | 0 | 1 | 1 |
| 2015 1 | 0 | 3 | 3 |
| 2015 11 | 0 | 2 | 2 |
Mostrar todo
